Treatment-resistant depression complicates care, defying standard treatments, but new therapies are on the horizon, offering hope for more effective treatment options.

A study being published in the journal Pharmacology Research & Perspectives found that psilocin, the active metabolite of psilocybin, “exhibits significant therapeutic potential in the treatment of ...

Intra-Cellular Therapies’ CAPLYTA is making waves in the antipsychotic market, gaining traction as a novel treatment for schizophrenia and bipolar depression. With its differentiated safety profile ...

Explore new findings on bipolar disorder, from genetics to sleep patterns, plus emerging treatments and a neuroscientist’s ...